期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状旁腺激素治疗骨质疏松症的研究进展 被引量：35

The progression of PTH supplements on osteoporosis
下载PDF
导出
摘要 甲状旁腺激素(PTH)及重组人甲状旁腺激素(rhPTH)作为骨形成促进剂可以有效促进骨骼重建,增加骨密度,预防骨折发生,越来越受到人们的关注。本文对PTH及rhPTH的基础研究、动物实验以及临床观察进行综述。 Parathyroid hormone （PTH） and recombinant human parathyroid hormone （rhPTH） as bone formation agents are receiving increasing attention. This review is mean to illustrate its basic research, animal experiment and clinical observation briefly.
作者 刘明 潘薇 陈德才
机构地区 四川大学华西医院内分泌代谢科
出处 《中华骨质疏松和骨矿盐疾病杂志》 2012年第2期151-156,共6页 Chinese Journal Of Osteoporosis And Bone Mineral Research
关键词 骨质疏松 甲状旁腺激素 骨形成促进剂 osteoporosis parathyroid hormone bone formation agents
分类号 R681 [医药卫生—骨科学]
  • 相关文献

参考文献21

  • 1Prank K,Noelan SJ,Hanns HM. Tine series prdiction of plasma hormone concentrayion[J].Clinical mvest,1995.2910-2916.
  • 2Pfeilschifter J,Mundy GR. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones[J].Proceedings of the National Academy of Sciences(USA),1987.20242-22028.
  • 3Hock JM,Centrella M,Canalis E. Insulin2like growth factor2I(IGF2I)has independent effects on bone matrix formation and cellreplication[J].Endocrinology,1988.254-260.
  • 4Rosen D,Miller SC,Deleon E. Systemic administration of re 2 combinant transforming growth factor beta 2(rTGF2β2)stimulatesparameters of cancellous bone formation in juvenile and adult rats[J].Bone,1994.355-359.
  • 5Johannes PD,Elisabeth Z,Eleftherios P. Treatment of osteoporosis with parathyroid hormone and teriparatide[J].Calcified Tissue International,2009.159-170.
  • 6Rubin MR,Bilezikian JP. New anabolic therapies inosteoporosis[J].Current Opinion in Rheumatology,2002.433-440.
  • 7Reeve J,Meunier PJ,Parsons JA. The anabolic effect of human parathyroid hormone fragment (hPTH 1-34) on trabecular bone volume in involutional osteoporosis:report of a multiple centre trial[J].British Medical Journal,1980.1340-1344.
  • 8徐进,荣海钦,王东,刘春艳,季虹.人甲状旁腺激素相关蛋白片段对骨质疏松大鼠股骨和腰椎骨密度的影响[J].中国老年学杂志,2006,26(1):51-54. 被引量：2
  • 9Mosekilde L,Sogaard CH,McLsker JE. PTH has more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents(esteogen and bisphosphonate) vassessed in sexually mature,ovariectomized rats[J].Bone,1994.401-408.
  • 10Hayashi K,Yamaguchi T,Yano S. BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH:potential therapeutic targets for glucocorticoid-induced osteoporosis[J].Biochemical and Biophysical Research Communications,2009.261-266.

二级参考文献16

  • 1Dempster DW. The impact of bone turnover and bone-active agents on bone quality:focus on the hip[ J ]. Osteoporos Int,2002;13:349-52.
  • 2Plotkin H, Gundberg C, Mitnick M, et al. Dissociation of bone formation from resorption during two-week treatment with hPTHrP(1-36) in humans: potential as an anabolic therapy for osteoporosis [ J ]. J Clin Endocrinol Metab, 1998 ; 83:2786-91.
  • 3Horwitz M J, Tedesco MB, Gundberg C, et al. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis[ J]. J Clin Endocrinol Metab,2003 : 88 : 569-75.
  • 4Stewrat AF,Cain RL, Burr DB,et al. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties : a comparison of human parathyroid hormone 1-34, para-thyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893[J]. J Bone Miner Res ,2000 ;15 : 1517-25,.
  • 5Rosen CJ, Bilezikian JP. Anabolic therapy for osteoporosis [ J]. J Clin Endocrinol Metab , 2001 ;86:957-64.
  • 6Cosman F, Nieves J, Woelfert L, et al. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal [ J ]. J Bone Miner Res,2001 ;16:925-31.
  • 7Kurland ES, Cosman F, MeMahon D J, et al. Parathyroid hormone as a therapy for idiopathic osteoporosis in men : effects on bone mineral density and bone markers [ J ]. J Clin Endocrinol Metab,2000 , 85 : 3069-76.
  • 8Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis[ J]. N Engl J Med ,2001 ;344 : 1434-41.
  • 9Dempster DW, Cosman F Kurland E, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study[ J]. J Bone Miner Res,2001 ;16:1846-53.
  • 10Du P, Ye Y, Seitz PK,et al. Endogenous parathyroid hormone-related peptide enhances proliferation and inhibits differentiation in the osteoblast-like cell line ROS 17/2. 8[J], Bone,2000;26(5) :429-36,.

共引文献1

同被引文献579

引证文献35

二级引证文献523

中华骨质疏松和骨矿盐疾病杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部